Jim Simons's position in Pfizer is currently worth $149 Million. That's 0.23% of their equity portfolio (86th largest holding). The first Pfizer trade was made in Q4 2013. Since then Jim Simons bought shares fourteen more times and sold shares on 21 occasions. The investor's estimated purchase price is $258 Million, resulting in a loss of 42%.